Navigation Links
Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
Date:11/18/2008

current liabilities 26,154,473 18,590,891 Long term debt payable (long term portion) -- 425,001 Long-term convertible promissory notes 5,489,742 2,875,075 Due to related parties (Long-term) 997,550 3,193,618 Total liabilities 32,641,765 25,084,585 Minority interest 5,607,044 5,502,755 Redeemable common stock, 2,049,560 shares at $3.6 per share 7,376,366 7,376,366 Shareholders' Equity Preferred stock, $0.001 par value; 5,000,000 shares authorized; None issued and outstanding -- -- Common stock, $0.001 par value; 150,000,000 shares authorized; 105,155,355 shares issued and outstanding as of 9/30/2008; 100,170,071 shares issued and outstanding as of 12/31/2007 105,155 100,170 Additional paid in capital 22,108,427 21,547,929 Retained earnings (unrestricted) (4,564,049) 100,452 Statutory surplus reserve fund 2,310,681 2,310,681 Accumulative other comprehensive income 6,387,795 3,390,774 Shares issuable for acquisition and services 503,860 503,860 Total Shareholders' Equity 26,851,869 27,953,866 Total Liabilities & Shareholders' Equity $72,477,044 $65,917,572
'/>"/>
SOURCE Benda Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Benda Pharmaceutical Files Amendment To Form S-1
2. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
3. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
4. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
7. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
10. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
11. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, 2014 ... Country Club, 1360 Almshouse Road, Warrington, Pa. , ... solely dedicated to finding a cure for hepatitis B and ... host its annual Crystal Ball on Friday, April 11 at ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the leader ... the new Director of Product Strategy. In this role, Michelle ... iLab sub-teams to guide in the development of iLab products. ... the maximum possible benefit to the scientific community by offering ...
(Date:1/14/2014)... ®, provider of RapidResponse ®, a cloud-based supply chain ... S&OP ) service, is proud to be a gold sponsor ... at the Hilton San Diego Bayfront, January 30 – 31, ... , Director of Supply Chain at Amgen, as she presents ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... and MTA: CTIC) today announced that a single institutional ... 15% Convertible,Senior Notes due 2011, with an initial conversion ... approximately 14.6 million shares of common stock,with an exercise ... a partial exercise of a previously granted,warrant right for ...
... of 14% ... 2009 Revenue Guidance, HOUSTON, June 11 Cyberonics, Inc. (Nasdaq:,CYBX) today ... Key quarterly highlights, Key results for the fourth quarter of ... -- Net sales of $33.9 million, an 8% increase from $31.4 million. ...
... Renewable Natural Gas ... and Other Waste Products, TARRYTOWN, N.Y., June 11 ... in the renewable bioenergy industry,will today mark the commencement ... a ground breaking ceremony. The Dublin, Texas,facility, owned and ...
Cached Biology Technology:Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor 2Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 2Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 3Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 4Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 5Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 6Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 7Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 8Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 9Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter 10Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 3Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 4Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5
(Date:4/17/2014)... Gauthier and Professor Luca Razzari of the nergie ... large grants from the John R. Evans Leaders ... for the acquisition of state-of-the-art biotech and nanophotonics ... grants from the Ministre de l,Enseignement suprieur, de ... Technologie (MESRST). These new laboratories will help us ...
(Date:4/17/2014)... news release is available in German . ... us to recognise objects; they also provide us with a ... run, turn around, fall or sit still in a car ... motion trace on our retinas. Seemingly without effort, our brain ... maintain a stable position and a steady gaze during our ...
(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... a gene required for stem cells in the brain to ... neuroblastoma, a deadly childhood cancer of the nervous system, according ... Cell today, the findings also provide clues about how ... Neuroblastoma can appear in nervous tissue in the abdomen, chest ...
... August 12, 2013 - Elsevier, a world-leading provider of ... pleased to announce the launch of Video Journal ... an open access video journal providing scientists and ... and step-by-step demonstrations and the first of its kind ...
... (BMI) appears to be stronger in adults without diabetes than ... Journal of General Internal Medicine in a study ... and colleagues. The researchers suggest that studies on body weight ... status in the population. In their analysis, Jackson,s ...
Cached Biology News:New insights into neuroblastoma tumor suppressor may provide clues for improved treatment 2Elsevier launches first video journal in gastrointestinal endoscopy 2Obesity and mortality association differs between individuals with and without diabetes 2
... are cytopathic effect inhibition assays, also known as ... tissue culture supernatents; serum from PK studies and ... is defined as the quantity of interferon required ... viral infection by 50%. All standards ...
Request Info...
...
...
Biology Products: